Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HYDRASOLVE LIPOPLASTY SYSTEM

K-Number: K130152 · 2013-04-18

ApplicantAndrew Technologies, LLC
Decision Date2013-04-18
Product CodeMUU
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

HYDRASOLVE LIPOPLASTY SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Andrew Technologies, LLC. It received FDA 510(k) clearance on 2013-04-18 under 510(k) number K130152. The device is classified under product code MUU. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HYDRASOLVE LIPOPLASTY SYSTEM?

HYDRASOLVE LIPOPLASTY SYSTEM is a medical device that received FDA 510(k) clearance on 2013-04-18. The listed applicant is Andrew Technologies, LLC. The 510(k) number is K130152.

When did HYDRASOLVE LIPOPLASTY SYSTEM receive FDA 510(k) clearance?

HYDRASOLVE LIPOPLASTY SYSTEM received FDA 510(k) clearance on 2013-04-18, under 510(k) number K130152.

Who is the listed applicant for HYDRASOLVE LIPOPLASTY SYSTEM?

The FDA 510(k) record lists Andrew Technologies, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HYDRASOLVE LIPOPLASTY SYSTEM?

The FDA product code for HYDRASOLVE LIPOPLASTY SYSTEM is MUU.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Andrew Technologies, LLC as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K121218HYDRASOLVE CONSOLE STERILE TREATMENT KIT REUSABLE CANNULA, 4MM DIA, 26 CM LENGTH, 3 APERTURE REUSABLE CANNULA, 4MM DIA,K092066PHASER LIPOPLASTY SYSTEM (DUR-01), PHASER DISPOSABLE KIT (DIS-01), PHASER WASTE COLLECTION KIT (WAS-01), PHASER CANNULAE

Related Devices (Code: MUU)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K210528IntelliFat Disposable Adipose Tissue Harvesting and Transfer Kit, IntelliFat Body On Demand (BOD) KitMillennium Medical Technologies Inc (Dba Cellmyx)K203800SyntrFuge SystemSyntr Health Technologies, Inc.K202443Smart Kit Basic, Smart Kit ProBsl Co., Ltd.K193539REVOLVE ENVI 600 Advanced Adipose SystemLifecell CorporationK193363Dermapose RefreshPuregraft, LLCK182732JTL-250-01Jointechlabs, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑